APPENDIX DTABLES

Publication Details

Table 1. Randomized trials of hepatocellular carcinoma screening in patients with chronic liver disease (PDF, 166K)

Table 2. Assessment of study methods for potential sources of bias in randomized trials of hepatocellular carcinoma screening (PDF, 165K)

Table 3. Cohort studies of screening for hepatocellular carcinoma in patients with chronic liver disease (PDF, 177K)

Table 4. Assessment of study methods for potential sources of bias in cohort studies of screening for hepatocellular carcinoma in patients with chronic liver disease (PDF, 189K)

Table 5. Randomized controlled trials comparing TACE to supportive care in patients with hepatocellular carcinoma (PDF, 166K)

Table 6. Assessment of study methods for potential sources of bias in randomized trials of TACE in patients with early-stage hepatocellular carcinoma (PDF, 128K)

Table 7. Cohort studies comparing resection, RFA, TACE, and OLT to supportive care in patients with hepatocellular carcinoma (PDF, 188K)

Table 8. Assessment of study methods for potential sources of bias in cohort studies of resection, OLT, RFA, and TACE in patients with hepatocellular carcinoma (PDF, 164K)

Table 9. Non-comparative observational studies of OLT, RFA, and TACE in patients with hepatocellular carcinoma (PDF, 182K)

Table 10. Summary of AASLD, APASL, and EASL-EORTC guidelines for screening for hepatocellular carcinoma (PDF, 166K)

Table 11. AGREE II quality assessment of guidelines for screening for hepatocellular carcinoma (PDF, 186K)